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Breast neoplasm is the most frequent incident cancer among 
women worldwide (Ferlay et al., 2012). Although population 
screening programs for early detection have recently been 
surrounded by heated debates regarding their benefi ts (Miller et al., 
2014), the majority of health organizations continue recommending 
the use of screening mammography to decrease mortality by 
reducing rates of advanced breast cancer. The cost effi ciency of 
these programs is only achieved if they cover the whole target 
population (Perry et al., 2008); therefore, the concern of public 
health organizations is to reach high participation rates. In Spain, 
65% of the women invited to participate in these programs are 
recruited by the breast cancer early detection program. Participation 
rate in Asturias, the region in which this study was performed, is 
slightly better (74.2%) but it does not reach the desired rate (75.0%) 
for this kind of program (Castells et al., 2007). 
Theoretically, women’s worries about cancer might encourage 
their adherence to cancer screening strategies (Hay, Mc Caul, & 
Magnan, 2006). However, once a woman has decided to join the 
screening program, experiencing anxiety during the mammography 
exam could infl uence her further participation (Consedine, Magai 
Krivoshekova, Ryzewicz, & Neugut, 2004; Magai, Consedine, 
Neugut, & Hershman, 2007; Watson-Johnson et al., 2011).
In this sense, it is known that mammography screening usually 
involves psychological or emotional discomfort. Many women 
experience anxiety due to fear of results (Brett, Bankhead, 
Henderson, Watson, & Austoker, 2005; Consedine et al., 2004; 
Mainiero, Schepps, Clements, & Bird, 2001).
 ISSN 0214 - 9915 CODEN PSOTEG
Copyright © 2015 Psicothema
www.psicothema.com
A brief nursing intervention reduces anxiety before breast cancer
screening mammography
Ana Fernández-Feito, Alberto Lana, Ricardo Baldonedo-Cernuda and María Pilar Mosteiro-Díaz
Universidad de Oviedo
Abstract Resumen
Background: Anxiety experienced by women during their participation 
in breast cancer screening programs can condition their adherence to the 
program. The aim was to determine whether a brief nursing intervention 
could reduce anxiety before screening mammography. Method: A 
randomized controlled trial carried out with 436 Spanish women aged 
between 50-69 years, who attended a population breast cancer screening 
program. The experimental group received an ad-hoc tailored intervention, 
which consisted of offering information about the screening program and the 
mammography exam, as well as of providing personal emotional support. 
Anxiety was assessed using the State-Trait Anxiety Inventory (STAI). Fear 
of screening outcome and fear of breast cancer were also assessed. Results: 
Women of the experimental group had 60% less probability of having 
a high anxiety state (OR = 0.40; 95%: CI [0.25, 0.65]), after adjusting 
for sociodemographic and clinical variables. Regarding trait anxiety, 
no differences were observed between groups. The stratifi ed analysis 
showed that this positive impact was greater in women who did not fear 
the screening outcome (OR = 0.24; 95% CI [0.11, 0.52]) or breast cancer 
(OR = 0.07; 95% CI [0.01, 0.41]). Conclusions: A protocolized nursing 
intervention reduced the probability of being anxious when undergoing a 
screening mammography.
Keywords: Anxiety; Mammography; Nursing; Intervention Studies.
Una intervención enfermera breve disminuye la ansiedad antes de una 
mamografía de screening de cáncer de mama. Antecedentes: la ansiedad 
experimentada por las mujeres durante su participación en el examen de 
detección precoz del cáncer de mama puede condicionar su adherencia al 
programa. El objetivo fue determinar si una intervención enfermera breve 
disminuye la ansiedad antes de una mamografía de screening. Método: 
ensayo clínico controlado y randomizado en 436 mujeres españolas de 50 
a 69 años participantes en el programa de screening. El grupo experimental 
recibió una intervención diseñada ad-hoc, consistente en ofrecer 
información sobre el programa y la mamografía, así como proporcionar 
apoyo emocional. La ansiedad fue medida con el inventario de ansiedad 
estado-rasgo (STAI). También se evaluaron el miedo a los resultados y al 
cáncer de mama. Resultados: la probabilidad de tener ansiedad estado 
elevada fue un 60% menor en las mujeres del grupo experimental (OR 
= 0,40; IC95%: 0,25-0,65), tras ajustar por variables sociodemográfi cas y 
clínicas. Respecto a la ansiedad rasgo no se observaron diferencias entre 
grupos. El análisis estratifi cado mostró que el impacto positivo fue mayor 
en las mujeres sin miedo a los resultados (OR = 0,24; IC95%: 0,11-0,52) 
ni al cáncer de mama (OR = 0,07; IC95%: 0,01-0,41). Conclusiones: una 
intervención enfermera protocolizada disminuyó la probabilidad de tener 
ansiedad antes de la realización de una mamografía de screening.
Palabras clave: ansiedad; mamografía; enfermería; estudios de 
intervención.
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Other elements of the screening, such as the lack of information 
or long waiting lists, can also increase the negative view of this 
program (Brett et al., 2005). Moreover, obtaining an uncertain 
outcome, which requires complementary tests, also has a great 
emotional impact on women (Sandín, Chorot, Valiente, Lostao, & 
Santed, 2001). 
Few interventions to reduce women’s anxiety in relation to a 
mammography have been tested. Their results are diverse. Two 
interventions based on relaxing music (Domar et al., 2005) or a 
cancer prevention video (Mainiero et al., 2001) have not had a 
positive impact on reducing anxiety. However, the intervention of 
Caruso (2001) reduced anxiety in women by providing information 
and emotional support. But, in this case, the trial was performed 
among women who had already been diagnosed with breast cancer 
and not in the context of a population screening program. 
Thus, the aim of this study was to assess the impact of an 
intervention based on providing information and emotional support 
on anxiety and fear related to mammography screening.
Method
Participants
A randomized controlled trial was conducted during 2011 among 
women aged 50-69 who underwent a mammography in the context 
of the breast cancer population screening program in two Spanish 
state hospitals – the Hospital Foundation of Avilés (Hospital 1) and 
the Adaro Sanatorium Foundation in Langreo (Hospital 2). Women 
were randomly selected from the list of participants in the screening 
program (N = 8,781) and were invited to participate in the study. 
It was voluntary and none of the women received compensation. 
A sample of 436 women was recruited from January to December 
2011, and then randomly assigned to study groups. 
Instruments 
Main outcomes: anxiety and fear. Anxiety was assessed using 
the State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch, 
& Lushene, 1970), which has been validated in Spain (Guillén-
Riquelme & Buela-Casal, 2011). This questionnaire evaluates two 
components of anxiety: (a) State Anxiety, which is considered 
a subjective and temporary strain, and b) Trait Anxiety, which 
assesses the presence of a personal trait that tends to perceive certain 
situations as threatening. The STAI assesses each component with 
a 20-item scale which has four response options. These range 
from 0= (Not at all) to 3 (Very much) in State Anxiety, and from 0 
(Almost never) to 3 (Almost always) in Trait Anxiety. The score for 
each component ranges from 0 to 60, so a higher score indicates a 
higher anxiety. In addition, we asked women whether they feared 
of the screening outcome and breast cancer.
Sociodemographic and clinical variables. We also collected 
data on variables which might be potential confounders of the 
study association. Specifi cally, we asked the women about the 
following socio-demographic characteristics: age in years, size 
of population of residence (<2,000; 2,000-10,000; or >10,000 
inhabitants), medical center (hospital 1 or hospital 2), marital 
status (single, married/living together, divorced/separated or 
widowed), number of children (none, 1 child, 2 children, 3 or more 
children), and education level (none, primary school, secondary 
school/professional training or university). Moreover, we also 
obtained some clinical information regarding health-related 
variables and family history of cancer: regular caffeine intake (yes 
or no), regular intake of anxiolytic and/or antidepressant drugs 
(yes or no), menopause (yes or no), presence of breast pathology 
(no, fi brocystic disease or other), family history of breast and 
non-breast cancer (yes or no). Finally, we collected data on 
several important screening-related variables: previous screening 
mammographies (yes or no), breast tenderness (yes or no), pain in 
previous mammographies (yes or no), fear of screening outcome 
(yes or no), fear of breast cancer (yes or no) and expected pain in 
the current mammography (yes or no).
Procedure
The control group (CG, n = 205) received normal care (i.e. the 
health staff followed the usual procedure), whereas women in the 
experimental group (EG, n = 231) also received a protocolized 
nursing intervention (see fl ow diagram in Figure 1). This 
intervention provided face-to-face general information about the 
population screening program as well as emotional support. In 
summary, before accessing the radiology room, a trained nurse 
provided general information on the screening program, such as 
the objectives of the program, the benefi ts of an early detection, 
and the whole procedure (from the recruitment to the results 
reception). Specifi c information on the mammography exam, such 
as what a mammography is, the length of the exam, the position 
of the women, and the feelings they may experience were also 
stated. Several images were used to support the explanation. 
Subsequently, the same nurse offered the women an opportunity 
Women recruited for the screening program in Hospital 1
and 2 during the year 2011 (N = 8,781)
Random sample
(N = 453)
Definitive sample
(N = 436)
Evaluation of sociodemographic and clinical
characteristics
Randomization process
CG
(n = 205; 47.0%)
EG
(n = 231; 53.0%)
Usual care Protocolized nursingintervention
Anxiety evaluation
Mammography exam
Refuse to participate
(n = 17; 3.8%)
CG: Control Group, EG: Experimental Group
Figure 1. Flow diagram of the randomized controlled trial
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to talk about other topics related to the exam and breast cancer, 
as well as expressing their possible feelings of anxiety, fear, or 
asking questions. The whole intervention lasted around 10 minutes 
- 5 minutes for information and 5 minutes for emotional support. 
Anxiety was assessed just before performing the mammography, 
that is, after women of the EG had received the intervention, as 
well as after the usual care to women of the CG was provided 
(Figure 1).
The study was approved by the Ethics Committee of Clinic 
Research (Asturias Central University Hospital) and all participants 
gave their informed consent. The randomized control trial complied 
with the principles of the Declaration of Helsinki.
Data analysis
The comparison of both study groups (CG and EG) was 
performed using the Pearson’s chi-square test. The effect of 
the intervention on anxiety was assessed using two types of 
multivariate analyses. First, logistic regressions explored the 
probability of having an anxiety score higher than the sample 
median (i.e., state anxiety >13 points and trait anxiety >21 points) 
if the women belong to the EG, compared with those of the CG. 
Second, linear regressions were used to study the association 
between the study groups and the anxiety scores, considering 
them continuous variables. All odds ratios (OR), B coeffi cients and 
their 95% confi dence intervals (95% CI) obtained from regression 
analyses were adjusted according to the above-mentioned potential 
confounders. Moreover, we performed some stratifi ed analyses 
according to fear variables, as we found interaction between fear 
of screening outcome and fear of breast cancer with the components 
of anxiety (p<.05). Statistical signifi cance was set at 2-tailed p<.05. 
Statistical analyses and the process of randomization were both 
performed using the SPSS software version 21.0 (IBM Corporation).
Results
A total of 436 women took part in the randomized control trial, 
231 (53.0%) in the CG and 205 (47.0%) in the EG (Figure 1). 
As shown in Table 1, most of the women were aged 55-59 years 
old, were recruited at hospital 2, were married, had two children 
and had attained reached only primary education. With regard to 
clinical variables, one out of four had been treated for anxiety or 
depression. Most of them had had some family experience of cancer 
and had no breast pathology at the time of the study. Randomization 
produced comparable groups for all sociodemographic and clinical 
variables of Table 1. Moreover, there was no difference between 
groups regarding pain variables. In the CG, 86.8% of the women 
had no pain prior to the mammography exam (breast tenderness). 
This percentage was 87.3% (p = .97) in the EG. In this sense, 
prevalence of pain in previous mammographies was similar (p = 
.98) between the CG (39.5%) and the EG (39.1%). Finally, there 
was no signifi cant difference in the expected pain rates: 20.0% in 
the CG and 25.5% in the EG (p = .17).
The overall effect of the intervention on the two components 
of anxiety is shown in Table 2. Women of the EG had 60% less 
probability of scoring in State Anxiety above the median (OR: 
0.40, 95% CI [0.25, 0.65]). Moreover, when anxiety is considered 
a continuous variable, the adjusted mean (standard deviation) of 
the State Anxiety score was signifi cantly lower among the women 
of the EG (13.02 ± 7.61) compared with those of the CG (15.93 ± 
6.16). In this sense, the linear regression showed that belonging 
to the EG diminished the mean State Anxiety score (B adjusted 
coeffi cient: -1.91; CI95%: [-3.10]-[-0.72]). These associations 
were not found for Trait Anxiety.
The stratifi ed analyses showed that the positive impact of the 
intervention was independent of both types of fear taken into 
account in our study: either fear of the mammography outcome 
or fear of breast cancer. However, in both cases, the intervention 
was more effective in women without fear (Table 3). According 
to the results of the linear regression, women without fear of the 
screening outcome had a lower State Anxiety score when they 
Table 1
Sociodemographic and clinical characteristics of the sample and comparison 
between the study groups
Total CG EG p-value
Participants, n (%) 436 205 (47.0) 231 (53.0)
Age, % .91
50-54 years 
55-59 years 
60-64 years 
65-69 years 
24.3
30.3
23.2
22.2
23.9
30.7
22.0
23.4
24.7
29.9
24.2
21.1
Population, % .30
<2,000 inhabitants
2,001-10,000 inhabitants
>10,000 inhabitants
29.2
19.3
51.5
32.7
19.0
49.3
26.1
19.6
54.3
Center, % .35
Hospital 1
Hospital 2
34.8
65.2
33.7
66.3
35.9
64.1
Marital status, % .52
Single
Married
Separated/Divorced
Widow
5.0
73.4
7.6
14
5.9
70.2
7.8
16.1
4.3
76.2
7.4
12.1
Education level, % .77
None
Primary school
Secondary school
University
10.8
61.2
18.6
9.4
9.8
61.0
18.5
10.7
11.7
61.5
18.6
8.2
Number of children, % .94
None
One child
Two children
Three or more children
10.3
25.9
42.9
20.9
9.8
25.4
44.4
20.5
10.8
26.4
41.6
21.2
Regular caffeine consumption, % 64.7 62.9 66.2 .30
Anxiolytic or antidepressants, % 27.1 23.4 30.3 .07
Menopause, % 96.1 95.2 97.1 .59
Breast pathology, % .27
No
Fibrocystic disease
Other pathologies
77.5
11.9
10.6
77.1
10.2
12.7
77.9
13.4
8.7
Family history of cancer, % 62.8 66.6 61.8 .33
Family history of breast cancer, % 19.3 20.5 18.2 .54
Previous mammographies; % 96.3 97.6 95.2 .22
CG: Control group; EG: Experimental group
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belong to the EG (11.92 ± 8.2) than when belonging to the CG 
(14.99 ± 8.3). The same fi gures for women without fear of breast 
cancer were: 11.26 ± 10.12, for those of the EG, and 14.82 ± 10.88 
for the women of the CG. The matching coeffi cients of the linear 
regression showed that the intervention had a positive impact on 
the Trait Anxiety score among women without fear of the screening 
outcome (B adjusted coeffi cient: -3.06; 95%CI: [-4.69]-[-1.44]) 
and without fear of breast cancer (B adjusted coeffi cient: -3.56; 
95%CI: [-5.74]-[-1.37]). As above, these results were found only 
for State Anxiety, never for Trait Anxiety. 
Discussion 
In this randomized control trial, a brief and protocolized 
intervention implemented by a trained nurse achieved a signifi cant 
reduction in the state of anxiety among Spanish women who 
participated in the breast cancer screening population program.
Although women who participate in breast cancer screening 
programs are usually healthy or asymptomatic, anxiety is one 
of the feelings most frequently mentioned (Brown Sofair & 
Lehlbach, 2008; Cardenal et al., 2008; Consedine et al., 2004). 
Some of the main causes of anxiety are expected pain during the 
mammography, the possibility of having to deal with a positive 
result, or being called back for another secondary examination 
(Sandin et al., 2001). Therefore, addressing anxiety should have a 
twofold purpose: (a) in the short-term, ensuring the highest level of 
well-being among women attending the service and (b) in the long-
term, to increase women’s adherence to the screening program, 
since well-being during a mammography examination is likely to 
improve satisfaction with the program. Thus, theoretically, dealing 
with anxiety could increase the overall survival rates of the women 
screened. 
In our study, there was a signifi cantly higher percentage of 
women with a lower State Anxiety score among the women 
who received the nursing intervention (EG). It was suspected 
that a brief informational intervention with some components of 
emotional support does not achieve a reduction in the trait anxiety. 
Modifi cation of trait anxiety probably needs a psychological and, 
generally speaking, a more complex approach. However, reducing 
State Anxiety should be suffi cient to improve the overall satisfaction 
with breast cancer screening programs. This type of intervention 
had already proved to be effective in reducing both the anxiety 
and the pain of mammography examination during the clinical 
follow-up after breast cancer (Caruso et al., 2001). The benefi ts of 
these counseling interventions have also been observed in women 
who had obtained a previous abnormal result in a screening 
mammography (Bowland et al., 2003). However, our study seems 
to be the fi rst one to demonstrate that the interventions can also 
have a positive impact among women attending a routine screening 
program. Interventions tested by other researchers, which included 
relaxing audiotape music (Domar et al., 2005) or an educational 
videotape about breast cancer and mammography (Mainiero et 
Table 2
Overall effect of the intervention on both components of anxiety
≤ Median > Median OR (95% CI)* p-value
State anxiety, %
CG (n = 205)
EG (n = 231)
45.9
59.7
54.1
40.3
1.00 (Ref.)
0.40 (0.25-0.65)
<.001
Trait anxiety, %
CG (n = 205)
EG (n = 231)
52.7
51.5
47.3
48.5
1.00 (Ref.)
1.27 (0.76-2.08)
.34
CG: Control group; EG: Experimental group
* Odds ratio from logistic regressions adjusted by: age (50-54, 55-59, 60-64 or 65-69 
years), population size (<2,000, 2,001-10,000 or >10,000 inhabitants), center (hospital 1 
or hospital 2), marital status (single, married, separated/divorced or widow), education 
level (none, primary, secondary or university), number of children (none, one, two, three 
or more children), regular caffeine consumption (yes or no), anxiolytic or antidepressants 
consumption (yes or no), menopause (yes or no), breast pathology (no, fi brocystic disease 
or others pathologies), family history of cancer (yes or no), family history of breast cancer 
(yes or no), breast tenderness (yes or no), previous screening mammographies (yes or no), 
pain in previous mammographies (yes or no), expected pain in the current exam (yes or 
no), fear of screening outcome (yes or no), fear of cancer (yes or no) and anxiety (state 
anxiety or trait when necessary)
Table 3
Effect of the intervention on both components of anxiety according to women’s 
fear of screening outcome and of breast cancer
≤ Median > Median OR (95% CI)* p-value
Without fear of outcome
State anxiety, %
CG (n = 93)
EG (n = 108)
53.8
75.0
46.2
 25.0
1.00 (Ref.)
0.24 (0.11-0.52)
<.001
Trait anxiety, %
CG  (n = 93)
EG (n = 108)
57.0
56.5
43.0
43.5
1.00 (Ref.)
1.10 (0.46-2.59)
.84
With fear of outcome
State anxiety, %
CG (n = 112)
EG (n = 123)
39.3
46.3
60.7
53.7
1.00 (Ref.)
0.54 (0.26-1.11)
.09
Trait anxiety, %
CG (n = 112)
EG (n = 123)
 
49.1
47.2
50.9
52.8
1.00 (Ref.)
1.13 (0.56-2.30)
.74
Without fear of cancer
State anxiety, %
CG (n = 46)
EG (n = 56)
54.3
78.6
45.7
21.4
1.00 (Ref.)
0.07 (0.01-0.41)
.003
Trait anxiety, %
CG (n = 46)
EG (n = 56)
60.9
55.4
39.1
44.6
1.00 (Ref.)
5.30 (0.59-47.72)
.14
With fear of cancer
State anxiety, %
CG (n = 159)
EG (n = 175)
43.3
53.7
56.6
46.3
1.00 (Ref.)
0.39 (0.22-0.70)
.002
Trait anxiety, %
CG (n = 159)
EG (n = 175)
50.3
50.3
49.7
49.7
1.00 (Ref.)
1.20 (0.67-2.16)
.53
CG: Control group; EG: Experimental group
* Odds ratio from logistic regressions adjusted by: age (50-54, 55-59, 60-64 or 65-69 
years), population size (<2,000, 2,001-10,000 or >10,000 inhabitants), center (hospital 1 
or hospital 2), marital status (single, married, separated/divorced or widow), education 
level (none, primary, secondary or university), number of children (none, one, two, three 
or more children), regular caffeine consumption (yes or no), anxiolytic or antidepressants 
consumption (yes or no), menopause (yes or no), breast pathology (no, fi brocystic disease 
or others pathologies), family history of cancer (yes or no), family history of breast cancer 
(yes or no), breast tenderness (yes or no), previous screening mammographies (yes or no), 
pain in previous mammographies (yes or no), expected pain in the current exam (yes or 
no), fear of screening outcome (yes or no), fear of cancer (yes or no) and anxiety (state 
anxiety or trait when necessary)
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al., 2001) did not achieve a positive impact on the anxiety level. 
The context in which the samples of these two studies were taken 
may mean that both the detection programs and the participating 
women are different from those of our study, and therefore are 
scarcely comparable. In any case, personal interaction can be the 
key element. Perhaps personal guidance and direct support while 
women are waiting for examination provides relaxation, as they 
are able to express their feelings, as well as to receive the answers 
to their questions regarding the procedure. Therefore our results 
suggest that trained staff should accompany women as they arrive 
at the radiology department. Subsequently, further research should 
test the hypothesis that lower anxiety improves adherence to the 
screening program. Moreover this hypothesis is coherent with the 
opinion of other experts, who point out that worry and fear of the 
examination are the main reasons for refusing to participate in a 
screening program (Barroso García, Ruiz Pérez, de Rojas, Parrón 
Carreño, & Corpas Nogales, 2009; Kang, Thomas, Kwon, Hyun, & 
Jun, 2008; Luengo-Matos, Polo-Santos, & Saz-Parkinson, 2006).
In the scientifi c literature, anxiety has usually been linked with 
fear, either of the procedure itself or of breast cancer (Mainiero et 
al., 2001; Brett et al., 2005). But the role of fear is complex. In 
some women, anxiety due to mammography may be largely due to 
fear of the screening outcome or fear of cancer. In these women, 
an intervention like ours, which was only focused on reducing 
anxiety, would not work properly. However, our intervention 
was effective in women with and without fear. That is to say that 
having more information and feeling accompanied decreased 
State Anxiety regardless of fear. This may be due to the fact that 
not all of the anxiety for these women was caused by fear of the 
screening outcome or fear of cancer; but of the mammography 
examination itself. Our intervention therefore seems effective in 
reducing anxiety caused by a mammography. For this reason, the 
intervention was more effective in women who had no fear than in 
those who did.
Randomized controlled trials are arguably the best way 
of establishing causality; this was the main strength of our 
study. Another strong point was the adjustment for a large list 
of confounders, such as breast tenderness, pain in previous 
mammographies and expected pain in the current exam. All of 
these factors could be important modulators of anxiety. A key 
limitation of the study was the assessment of anxiety only after the 
intervention, so changes in anxiety could not really be assessed. 
But, as the intervention was brief, answering the same questionnaire 
for a second time only 10 minutes later could introduce a response 
bias. It would have been interesting to have measured anxiety level 
in both groups several days after the test in order to determine 
whether the effect of the intervention is maintained over time. 
In addition, random assignment of women achieved comparable 
study groups in all variables. Therefore, it is expected that they 
were also comparable in terms of anxiety before the intervention. 
In conclusion, a brief nursing intervention based on providing 
information and emotional support may reduce state anxiety among 
the participants of a breast cancer screening program before a 
mammography exam. The effectiveness of the intervention was 
independent of fear concerning screening outcome and breast cancer; 
however it achieved a higher impact on women without fear. 
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